Navigation Links
Licorice May Block Absorption of Organ Transplant Drug
Date:3/25/2009

Study finds potential interaction with cyclosporine could lead to fatal complications

TUESDAY, March 24 (HealthDay News) -- People taking the immunosuppressant cyclosporine should avoid consuming licorice because it may weaken the drug's effectiveness and possibly lead to deadly consequences, new research suggests.

Chemists in Taiwan report that lab rats taking cyclosporine -- commonly used to help prevent organ rejection in transplant patients -- who were feed licorice or its main active ingredient, glycyrrhizin, did not absorb the medication well. For a transplant patient on cyclosporine, lowered levels of the medication could lead to rejection of the new organ, followed by illness and even death, said the researchers, who were to present their findings Tuesday at the American Chemical Society's annual meeting in Salt Lake City.

"I would suggest that transplant patients avoid taking licorice," researcher Pei-Dawn Lee Chao, a chemist at China Medical University in Taichung, Taiwan, said in an American Chemical Society news release.

The researchers, who are trying to determine why licorice interfered with the drug's absorption, said they didn't know how much licorice might cause a toxic reaction in humans.

Cyclosporine is also used to treat rheumatoid arthritis, juvenile myositis and various skin conditions, and it is known to interact poorly with some medicines, foods and herbs. St. John's wort, onions and ginger, for example, can also lower cyclosporine levels in the blood, while grapefruit juice can sending cyclosporine levels soaring.

Licorice has been reported to possibly interfere with high blood pressure medications, aspirin, anti-inflammatory drugs, insulin and oral contraceptives. The herb has been popular in folk medicine for centuries and is used by some combat stomach ulcers, bronchitis and sore throat. Because of its sweetness, glycyrrhizin is sometimes used in candy, teas and other foods.

More information

The U.S. National Center for Complementary and Alternative Medicine has more about licorice.



-- Kevin McKeever



SOURCE: American Chemical Society, news release, March 24, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Licorice compound offers new cancer prevention strategy
2. Licorice extract provides new treatment option for canker sores
3. Hebrew University scientist develop technique for eliminating reblockage of arteries
4. Drug blocks two of worlds deadliest emerging viruses
5. Drug blocks 2 of worlds deadliest emerging viruses
6. United States Files Suit Against Missouri-Based Pharmaceutical to Block Manufacturing and Shipping of Unapproved Drugs
7. Market for Niche Blockbusters Promises an Attractive Future for Large Pharmaceutical Companies, Indicates Frost & Sullivan
8. NLRB Blocks New Organizations Attempts to Divide UHW; SEIU UHW Committed to Securing Good Contracts With Members
9. Blocking protein leads to fewer, smaller skin cancer tumors
10. Beta Blocker Blocks Feelings of Bad Memories
11. USC study finds that green tea blocks benefits of cancer drug
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Licorice May Block Absorption of Organ Transplant Drug
(Date:2/22/2017)... ... 2017 , ... The first-ever National Heart Valve Disease Awareness ... join together to increase recognition about the risks of heart valve disease (HVD) ... mark a nationwide movement to raise awareness about a disease that has not ...
(Date:2/22/2017)... ... February 22, 2017 , ... The Centers for Medicare & ... practices in Delaware, New Jersey, Pennsylvania and West Virginia prepare for and participate ... Reauthorization Act of 2015 (MACRA). , This technical assistance, authorized and funded ...
(Date:2/22/2017)... ... February 22, 2017 , ... Bellus Medical, a leader in ... the delivery of Platelet Rich Plasma (PRP). PRP systems are used by physicians ... tissue synthesis and provide a faster and more efficient healing process. There are ...
(Date:2/22/2017)... , ... February 22, 2017 , ... ... company, launched a new media platform connecting healthcare technology professionals and other key ... followed by a quarterly publication starting on March 1, announced Michael J. Hennessy, ...
(Date:2/22/2017)... ... , ... The SeniorCare Investor will host an important webinar— Seniors Housing M&A: ... 1:00 PM ET. A recording of the webinar will also be made available following ... you want to find out what really happened in the seniors housing and care ...
Breaking Medicine News(10 mins):
(Date:2/22/2017)... Research and Markets has announced the addition of the ... to their offering. ... Dermatological conditions are one of the most ... US population suffers from at least one active skin condition. ... has remained saturated with established and generic products. However, the ...
(Date:2/22/2017)... Research and Markets has announced the addition of ... Small Molecule Drugs), By Route of Administration (Systemic, Topical), By ... report to their offering. ... The global psoriasis drugs market is anticipated ... report provides a detailed analysis of the current and future ...
(Date:2/22/2017)... , Feb. 22, 2017  Tri-Source Pharma announced today ... A series of newly appointed positions were added to ... CEO, Robert DiCrisci , in the implementation and ... management of the recently consolidated subsidiary companies. ... team will be composed of the following eight members ...
Breaking Medicine Technology: